Saturday 17 October 2026
Export PGNY’s income statement to Excel — free account
Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 5.30%, EPS grew 80.0% and free cash flow fell 12.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
26.86
0.60
−2.18%
Follow PGNY
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 8 | 8 |
+8 more TTM periods Free account |
| 16.24% | 14.93% | 12.48% | 11.37% | ||
| 10.65% | 9.48% | 8.67% | 7.77% | ||
ROIC |
32.40% | 28.15% | 25.88% | 24.98% | |
Return on Tangible Assets |
24.97% | 22.45% | 15.43% | 12.97% | |
Average Days of Receivables |
71.70 | 74.41 | 62.39 | 72.64 | |
Free Cash Flow per Share |
2.28 | 2.28 | 2.24 | 2.25 | |
Free Cash Flow |
178.38 | 184.42 | 191.78 | 193.46 | |
Capital Expenditures |
(22.86) | (21.91) | (18.41) | (14.69) | |
| Other line items | |||||
Cash ROIC |
25.85% | 27.75% | 23.21% | 21.37% | |
Accounts Receivable Turnover |
4.95 | 4.59 | 5.66 | 4.76 | |
Accounts Payable Turnover |
6.76 | 6.47 | 8.98 | 7.71 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
56.13 | 58.70 | 46.01 | 45.95 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.34) | (0.36) | (0.39) | (0.41) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.02% | 16.65% | 17.01% | 16.17% | |
Share Based Compensation of Revenue |
8.18% | 9.21% | 10.23% | 10.08% | |
Operating CF/Net income |
2.56 | 3.05 | 3.59 | 3.68 | |
Depreciation/Fixed assets |
0.14 | 0.15 | 0.17 | 0.31 | |
Capex/Depreciation |
(3.98) | (4.12) | (3.72) | (1.89) | |
Revenue per Share |
16.77 | 15.98 | 15.05 | 14.75 | |
Operating CF per Share |
2.57 | 2.55 | 2.45 | 2.42 | |
Capex per Share |
(0.29) | (0.27) | (0.21) | (0.17) | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 |
Columns are period end dates